Oncology: Bristol Myers Squibb agrees to acquire… – Nuadox | Innovation, science and tech news
Oncology: Bristol Myers Squibb agrees to acquire Mirati for $4.8B- By Nuadox Crew – On October 8, Bristol Myers Squibb announced its acquisition of Mirati Therapeutics for $58.00 per share in cash,…